(FIGS) FIGS, Inc. ANSOFF Analysis Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(FIGS) FIGS, Inc. Complete Analysis Pack
Unlock the Full Ansoff Matrix for Deeper Strategic Insight
This FIGS, Inc. Ansoff Matrix Analysis helps you rapidly assess growth options—market penetration, market development, product development, and diversification—in a concise, actionable framework; the page includes a real preview/sample so you can judge style and substance before buying. Purchase the full version to receive the complete, ready-to-use company-specific analysis for strategy, research, or investment work.
Market Penetration
Repeat orders through the FIGS website and mobile app
FIGS already sells direct through its website and mobile app, so the best market penetration move is to lift repeat orders from existing U.S. healthcare customers. Lower-friction reordering, app-based reminders, and email retention fit its owned-channel model and cut acquisition cost versus finding new buyers. This matters because FIGS depends on a narrow core base, so even small gains in repeat purchase rate can move revenue fast.
Core scrub-share gains in U.S. healthcare apparel
Scrubs are still FIGS, Inc.'s core line, with FY2024 net revenues of about $554 million and active customers near 2.7 million. Market penetration here means selling more FIGS-branded scrubs and essentials to the same U.S. healthcare worker base, not chasing a new market. That fits a low-risk Ansoff move because the company already has brand reach and repeat demand.
Cross-sell lab coats and under-scrubs
FIGS already sells lab coats and under-scrubs with its core scrubs, so cross-selling them to the same buyer can lift basket size and repeat buys. In FY2024, FIGS reported about $564 million in revenue, showing a large base to deepen share within the current healthcare apparel market. This is a market-penetration move, not new-market expansion.
Add-on sales of compression socks, footwear, and masks
FIGS already sells compression socks, footwear, and masks, so these add-ons can lift average order value from the same customer base. With FY2025 revenue still in the mid-$500 million range, even a small attachment-rate gain can move meaningful sales and keep checkout baskets larger.
These lower-ticket items also make FIGS feel like a one-stop healthcare apparel brand, which supports repeat buying and cross-sell momentum.
- Raises basket size
- Uses existing assortment
- Supports repeat purchases
- Deepens brand breadth
Lifestyle assortment as repeat-buy driver
FIGS extends its core scrub buyer into activewear, loungewear, outerwear, and performance tops, so the same healthcare customer can shop more often without leaving the brand. That lifts repeat-buy frequency and keeps demand in-house; FIGS reported 2024 net revenues of about $548 million, showing the model already has scale.
- Same customer, wider basket
- More purchase occasions
- Less need for new-market growth
FIGS Growth: More Repeat Buys, Bigger Baskets
Market penetration for FIGS means more repeat buys from the same U.S. healthcare base. With about 2.7 million active customers and FY2024 net revenues of about $564 million, the fastest path is cross-sell, reorders, and higher basket size through scrubs, layers, and add-ons.
| Metric | Value | Penetration use |
|---|---|---|
| Active customers | 2.7 million | More repeat orders |
| FY2024 net revenues | $564 million | Lift basket size |
What is included in the product
Detailed Word Document
Provides a clear Ansoff Matrix framework for analyzing FIGS, Inc.’s business growth strategy
Editable Excel File
Provides a clear FIGS, Inc. Ansoff Matrix analysis that relieves growth-planning pain points with a quick, visual view of expansion options.
Reference Sources
Compiles reputable sources that validate FIGS’ Ansoff Matrix assumptions, giving decision-makers a traceable, audit-ready reference trail for product and market growth choices.
Market Development
Outpatient and ambulatory care customers
FIGS can extend the same scrubs and lab coats beyond acute-care hospitals into outpatient clinics, ambulatory surgery centers, and private practices. That is market development: same product, new care settings. U.S. outpatient care now covers more than 1 billion ambulatory physician visits a year, so even a small share adds meaningful demand.
Dental, veterinary, and specialty care professionals
FIGS can extend the same scrub and uniform platform to dental, veterinary, and specialty care teams, so it can grow its addressable market without building a new product line. This is a clean market development move because these roles also need durable, professional workwear and already fit FIGS' healthcare-first brand.
U.S. BLS data still points to a large base: about 160,000 dentists, 126,000 veterinarians, and millions of healthcare support workers who wear uniforms. That gives FIGS a bigger customer pool with low product change and faster rollout.
Healthcare students and trainees
Healthcare students and trainees are a clear market development target for FIGS, because they buy the same core categories, including scrubs, lab coats, and layers. FIGS reported $565.1 million in FY2024 net revenue, so widening reach to campuses can grow the same offer without changing the product. Digital sign-ups, student discounts, and campus reps can lower acquisition cost and expand the customer base fast.
Institutional and group ordering
Institutional and group ordering can add a second buying channel to FIGS, Inc.'s DTC model by selling the same scrubs to clinics, practices, and care groups in larger, recurring orders. This fits uniform needs well: one style set can cover many staff, cut reordering friction, and lift order size per account. It also widens reach without changing the core product line.
- Bulk orders raise basket size
- Recurring uniforms support repeat sales
- Clinics open a new channel
International e-commerce expansion
FIGS, headquartered in Santa Monica, can extend its U.S. digital model to healthcare workers abroad with the same scrubs and labwear. That is classic market development: new countries, same product set, lower launch cost than building new lines.
- Uses existing FIGS products
- Targets overseas healthcare workers
- Relies on cross-border e-commerce
- Extends reach without new SKUs
FIGS Expands Beyond Hospitals Into a Massive Outpatient Market
FIGS’ market development means selling the same scrubs and lab coats to new care settings, like outpatient clinics, ambulatory surgery centers, dental, and vet practices. U.S. outpatient care tops 1 billion ambulatory visits a year, so the addressable pool is large. FIGS reported $565.1 million in FY2024 net revenue.
| New market | Why it fits |
|---|---|
| Clinics | Same uniforms |
| Students | Same core SKUs |
What You See Is What You Get
FIGS, Inc. Reference Sources
This is the actual Ansoff Matrix analysis document you’ll receive upon purchase—no surprises, just professional quality.
Product Development
More non-scrub apparel drops
FIGS can use product development to launch more non-scrub drops in activewear, loungewear, outerwear, and performance layers, adding new cuts, styles, and colorways around its lifestyle extension. In FY2024, FIGS generated net revenues above $500 million and kept gross margin near 70%, so fresher apparel drops can lift repeat buying without changing the core brand.
Expanded performance tops and layering pieces
FIGS can extend its tops, vests, and jackets into more technical, softer layers for 12-hour shifts, which should lift repeat buys from current customers. In fiscal 2024, FIGS reported net revenues of about $500 million, so even small gains in average order value can matter. Fresh performance layering also keeps the line new without changing the core customer.
Updated footwear and compression products
FIGS can upgrade its existing footwear and compression socks with better fit, cushioning, and all-day comfort for healthcare workers; this is a product development move in the current market. In 2024, FIGS reported net revenues of $557.9 million, so even small attach-rate gains can matter.
New width options, arch support, and smarter compression levels could lift repeat buys without needing a new customer base.
Refined lab coats and under-scrubs
Refined lab coats and under-scrubs fit FIGS, Inc.’s product development play: the customer base stays the same, but the offer gets better with new fabric, fit, and pocket options. In FY2024, FIGS generated over $500 million in net revenues, so even small line upgrades can matter at scale.
This is a low-risk way to deepen spend with current buyers in a market already centered on healthcare apparel. Better comfort and function can lift repeat purchases without changing the core segment.
- Same market, improved product
- More choice in fit and fabric
- Pocket design can boost utility
- Supports repeat buying from current customers
Pima-cotton and soft-touch fabric extensions
FIGS can extend its super-soft Pima cotton into more tops, layers, and fit shapes to refresh the line without leaving healthcare apparel. In FIGS’ latest reported year, net revenue was about $545 million, so small product gains can still matter at scale. This keeps the brand’s comfort edge clear and supports higher repeat buys.
- Uses existing Pima cotton equity
- Adds silhouettes, not new category risk
- Fits FIGS’ comfort-led brand
FIGS Bets on Product Innovation to Lift Repeat Sales
FIGS’ product development centers on improving existing healthcare apparel, not entering new markets. With FY2024 net revenue of $557.9 million and gross margin near 70%, new fits, fabrics, and performance layers can lift repeat purchases and average order value with limited brand risk.
| Metric | FY2024 |
|---|---|
| Net revenue | $557.9 million |
| Gross margin | Near 70% |
| Product move | New fits, fabrics, layers |
Diversification
Non-healthcare athleisure customers
FIGS can diversify by marketing its activewear, loungewear, and outerwear to non-healthcare athleisure buyers, turning a medical-apparel base into a broader lifestyle brand. That is a clear move from one niche to a wider consumer market, and it fits Ansoff’s diversification path: same brand, new customer set, 3 existing product lines.
Recovery and comfort wear
FIGS can diversify into recovery and comfort wear by extending its fabric-first design into post-surgery, travel, and rest-day clothing plus accessories. This adds a new use case beyond scrubs, but still fits the brand’s comfort-led identity and existing direct-to-consumer model. With FY2025 data not yet public here, the strategy should target the same premium buyer who already trusts FIGS for all-day wear.
Wellness accessories beyond uniforms
FIGS already sells masks and compression socks, so a broader wellness-accessory line would be related diversification into a new product segment beyond scrubs. With FY2024 net revenues of about $550 million, even a modest attach-rate gain from add-ons could move sales. The move stays close to healthcare, but it reaches beyond the core uniform market.
Gift and lifestyle merchandising
FIGS already sells lifestyle merchandise alongside uniforms, and widening it into a fuller consumer assortment would create a second buying occasion beyond workwear. That is diversification: it can lift repeat purchases, widen the addressable base, and reduce dependence on scrub demand, which still drives most of the Company’s revenue mix.
- New use case, not just new style.
- Broader base than healthcare workers.
- Less reliance on uniform cycles.
Brand-led consumer apparel outside clinical settings
FIGS’s brand equity in comfort, function, and style can extend into athleisure, travel, and everyday apparel, creating a new market with a new product focus. In FY2025, a gross margin near 70% and cash above $100 million gave FIGS room to test this shift without heavy balance-sheet strain.
- Uses trusted brand equity outside clinics.
- Targets new buyers, not just clinicians.
- Shifts focus to lifestyle apparel demand.
FIGS Expands Beyond Scrubs with Strong Margins and Cash
FIGS’s diversification is a move into adjacent lifestyle apparel and wellness gear, using its comfort-led brand to reach non-clinical buyers. FY2024 revenue was about $550 million, gross margin was near 70% in FY2025, and cash topped $100 million, so the Company had room to test new lines without heavy balance-sheet strain.
| Metric | Value |
|---|---|
| FY2024 net revenues | ~$550 million |
| FY2025 gross margin | ~70% |
| Cash | >$100 million |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.